The global Pacemakers and Implantable Cardioverter Defibrillators (ICDs) market was valued at US$ 7.97 billion in 2023 and is projected to reach US$ 8.11 billion by 2030, at a CAGR of 7.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
"The Ultimate Guide to (Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market) : Download the Full Report"Pacemaker is a medical device that uses electric shocks to continuously and regularly stimulate the heart muscles to maintain the continuous beating of the heart. Implantable cardioverter defibrillators or automatic implantable cardioverter defibrillators are devices that can be implanted in the body and can perform cardioversion, defibrillation and pacing of the heart. Therefore, the device can correct most life-threatening arrhythmias. For patients at risk of sudden cardiac death due to ventricular fibrillation and ventricular tachycardia, ICD is the first-line treatment and preventive treatment.
By Type
Pacemakers
Implantable Cardioverter Defibrillators
By ApplicationHospitals
Speciality Clinics & Cardiac Centres
Ambulatory centres
Others
"The Ultimate Guide to (Pacemakers and Implantable Cardioverter Defibrillators (ICDs) Market) : Download the Full Report"
Locked
